Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,553.78
(
-0.41%
)
US TECH 100
23,350.40
(
-0.72%
)
Dow Jones
46,092.58
(
-0.25%
)
Brent Oil
100.16
(
3.48%
)
Bitcoin
70,060.00
(
-1.18%
)
News Focus
News Focus
Post# of 257275
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: randychub post# 6632

Monday, 01/10/2005 12:04:04 PM

Monday, January 10, 2005 12:04:04 PM

Post# of 257275
>>Celebrex is on the market for pain relief with those issues. I would expect to keep from going blind that a higher threshold of systemic events would be permitted.<<

Absolutely. The rate of acceptable cardiovascular SAE’s in AMD will be much higher than the acceptable rate for arthritis pain. But not as high as the acceptable rate for cancer.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today